Mukherjee A - Search Results

1

An Upgraded Solid-Phase Assembly of Chelators (DOTA and NOTA) Enabled Bacterial Uptake Studies of Radiolabeled Peptide.

Pati B, Kumar A, Chowdhury A, Tripathi NM, Gour V, Mukherjee A, Bandyopadhyay A. Pati B, et al. Among authors: mukherjee a. Chembiochem. 2024 Dec 10:e202400996. doi: 10.1002/cbic.202400996. Online ahead of print. Chembiochem. 2024. PMID: 39658876

2

Integrating a covalent probe with ubiquicidin fragment enables effective bacterial infection imaging.

Bhatt Mitra J, Chatterjee S, Kumar A, Bandyopadhyay A, Mukherjee A. Bhatt Mitra J, et al. Among authors: mukherjee a. RSC Med Chem. 2022 Aug 1;13(10):1239-1245. doi: 10.1039/d2md00190j. eCollection 2022 Oct 19. RSC Med Chem. 2022. PMID: 36325398 Free PMC article.

3

Expanding a peptide-covalent probe hybrid for PET imaging of S. aureus driven focal infections.

Bhatt Mitra J, Chatterjee S, Kumar A, Khatoon E, Chandak A, Rakshit S, Bandyopadhyay A, Mukherjee A. Bhatt Mitra J, et al. Among authors: mukherjee a. EJNMMI Radiopharm Chem. 2024 Mar 26;9(1):25. doi: 10.1186/s41181-024-00252-4. EJNMMI Radiopharm Chem. 2024. PMID: 38530487 Free PMC article.

4

Evaluation of ¹⁷⁷Lu-Labeled Pertuzumab F(ab')₂ Fragments for HER2-Positive Cancer Targeting: A Comparative In Vitro and In Vivo Study.

Sharma R, Mukherjee A, Kumar A, Sarma HD. Sharma R, et al. Among authors: mukherjee a. Cancer Biother Radiopharm. 2024 Feb;39(1):64-74. doi: 10.1089/cbr.2023.0108. Epub 2024 Jan 12. Cancer Biother Radiopharm. 2024. PMID: 38363819

5

Imaging of bacterial infection: Harnessing positron emission tomography and Cherenkov luminescence imaging with UBI-derived octapeptide.

Mitra JB, Mukherjee A, Kumar A, Chandak A, Rakshit S, Yadav HD, Pandey BN, Sarma HD. Mitra JB, et al. Among authors: mukherjee a. Drug Dev Res. 2023 Nov;84(7):1513-1521. doi: 10.1002/ddr.22103. Epub 2023 Aug 11. Drug Dev Res. 2023. PMID: 37571805

6

Exploring the potential of radiolabeled duramycin as an infection imaging probe.

Kumar A, Mitra JB, Khatoon E, Pramanik A, Sharma RK, Chandak A, Rakshit S, Mukherjee A. Kumar A, et al. Among authors: mukherjee a. Drug Dev Res. 2024 Feb;85(1):e22138. doi: 10.1002/ddr.22138. Epub 2023 Dec 11. Drug Dev Res. 2024. PMID: 38078492

7

Influence of PEGylation on HER2-targeting retro A9 peptide analogue.

Yadav SA, Vats VK, Sharma R, Mukherjee A, Satpati D. Yadav SA, et al. Among authors: mukherjee a. Nucl Med Biol. 2024 Nov-Dec;138-139:108963. doi: 10.1016/j.nucmedbio.2024.108963. Epub 2024 Oct 5. Nucl Med Biol. 2024. PMID: 39383591

8

Preparation and biological studies of 125I-DOTA-TATE.

Korde A, Pandey U, Banerjee S, Dev Sarma H, Mukherjee A, Venkatesh M. Korde A, et al. Among authors: mukherjee a. Appl Radiat Isot. 2007 Jun;65(6):687-90. doi: 10.1016/j.apradiso.2006.10.004. Epub 2006 Nov 29. Appl Radiat Isot. 2007. PMID: 17137786

9

Synthesis and ¹⁷⁷Lu Labeling of the First Retro Analog of the HER2-Targeting A9 Peptide: A Superior Variant.

Sharma AK, Sharma R, Das A, Chakraborty A, Rakshit S, Sarma HD, Mukherjee A, Das T, Satpati D. Sharma AK, et al. Among authors: mukherjee a. Bioconjug Chem. 2023 Sep 20;34(9):1576-1584. doi: 10.1021/acs.bioconjchem.3c00265. Epub 2023 Jun 28. Bioconjug Chem. 2023. PMID: 37379455

10

Design, synthesis and evaluation of ¹⁷⁷Lu-labeled inverso and retro-inverso A9 peptide variants targeting HER2-overexpression.

Kumar Sharma A, Sharma R, Dev Sarma H, Mukherjee A, Das T, Satpati D. Kumar Sharma A, et al. Among authors: mukherjee a. Bioorg Chem. 2023 Nov;140:106761. doi: 10.1016/j.bioorg.2023.106761. Epub 2023 Aug 4. Bioorg Chem. 2023. PMID: 37586132

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,390 results

Search Page

Filters